These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17606673)

  • 21. Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
    Sádaba B; Azanza JR; Quetglas EG; Campanero MA; Honorato J; Coronel P; Gimeno M
    Rev Esp Quimioter; 2007 Mar; 20(1):51-60. PubMed ID: 17530036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues.
    Frossard M; Joukhadar C; Erovic BM; Dittrich P; Mrass PE; Van Houte M; Burgmann H; Georgopoulos A; Müller M
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2728-32. PubMed ID: 10991852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
    Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
    Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and tissue penetration of cefoxitin in obesity: implications for risk of surgical site infection.
    Toma O; Suntrup P; Stefanescu A; London A; Mutch M; Kharasch E
    Anesth Analg; 2011 Oct; 113(4):730-7. PubMed ID: 21642605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the bioequivalence of different strengths of tablets containing clarithromycin.
    Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):588-93. PubMed ID: 15497665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration of doripenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers.
    Burian B; Zeitlinger M; Donath O; Reznicek G; Sauermann R
    Antimicrob Agents Chemother; 2012 Jan; 56(1):532-5. PubMed ID: 22083466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats.
    Liu P; Fuhrherr R; Webb AI; Obermann B; Derendorf H
    Eur J Pharm Sci; 2005; 25(4-5):439-44. PubMed ID: 15905079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
    Sauermann R; Burian B; Burian A; Jäger W; Höferl M; Stella A; Theurer S; Riedl M; Zeitlinger M
    J Antimicrob Chemother; 2013 Apr; 68(4):895-9. PubMed ID: 23212112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue penetration of cefpodoxime and cefixime in healthy subjects.
    Liu P; Müller M; Grant M; Obermann B; Derendorf H
    J Clin Pharmacol; 2005 May; 45(5):564-9. PubMed ID: 15831780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target site penetration of fosfomycin in critically ill patients.
    Joukhadar C; Klein N; Dittrich P; Zeitlinger M; Geppert A; Skhirtladze K; Frossard M; Heinz G; Müller M
    J Antimicrob Chemother; 2003 May; 51(5):1247-52. PubMed ID: 12668580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single- and Repeated-Dose Pharmacokinetics of Ceftaroline in Plasma and Soft Tissues of Healthy Volunteers for Two Different Dosing Regimens of Ceftaroline Fosamil.
    Matzneller P; Lackner E; Lagler H; Wulkersdorfer B; Österreicher Z; Zeitlinger M
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3617-25. PubMed ID: 27044549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers.
    Sahre M; Sabarinath S; Grant M; Seubert C; Deanda C; Prokocimer P; Derendorf H
    Int J Antimicrob Agents; 2012 Jul; 40(1):51-4. PubMed ID: 22584101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of microdialysis to clinical pharmacokinetics in humans.
    Müller M; Schmid R; Georgopoulos A; Buxbaum A; Wasicek C; Eichler HG
    Clin Pharmacol Ther; 1995 Apr; 57(4):371-80. PubMed ID: 7712664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cefpodoxime in plasma and subcutaneous fluid following oral administration of cefpodoxime proxetil in male beagle dogs.
    Kumar V; Madabushi R; Lucchesi MB; Derendorf H
    J Vet Pharmacol Ther; 2011 Apr; 34(2):130-5. PubMed ID: 21395603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure.
    Ullah S; Matzneller P; Zeitlinger M; Fuhr U; Taubert M
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1097-1106. PubMed ID: 31062064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis.
    Tomaselli F; Maier A; Matzi V; Smolle-Jüttner FM; Dittrich P
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2228-32. PubMed ID: 15155226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Panou C; Adamakis I; Giamarellou H
    J Urol; 2001 Jan; 165(1):97-9. PubMed ID: 11125373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.